Global strategies to reverse the rise of liver cancer Details About the Webinar Thursday, 27/11/2025 · 06:00 Santiago (GMT -3:00) Cost: Free

https://www.bigmarker.com/lancet-webinars/lgcw-liver-cancer?utm_bmcr_source=hubspot_email_reg2_lancethcc25_lgcw&_hsmi=390725574&_hsenc=p2ANqtz--9YVI_oozrqGYQLVR4qJqAvEC4SE3Jcl2knK2JXb57qJPrRq5zWig1jiSDw1QKu9vCLBp4i7jvZsfYAWeLHKi55dWUOw&hsCtaAttrib=195697774979 In case you missed it, we invite you to our Lancet Webinar on Global strategies to reverse the rise of liver cancer on Nov 27, 2025, at 09:00 GMT/10:00 CET, hosted as part of London Global Cancer Week 2025. Attendance is free with registration. Register now Chaired by Helena Wang, Asia Senior Executive Editor at The Lancet, and Vania Wisdom, Senior Executive Editor and Oncology Ambassador at The Lancet, hear from a panel of experts as they explore how the global community is tackling the rising trend of liver cancer, the differences in liver cancer epidemiology and management across regions, and the emerging threat of metabolic dysfunction-associated steatotic liver diseases (MASH) and its implications: Jian Zhou, Professor, Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, China Stephen Lam Chan, Professor, Department of Clinical Oncology, Chinese University of Hong Kong, China Jordi Bruix, Professor, Barcelona Clinic Liver Cancer (BCLC), Hospital Clínic Barcelona, IDIBAPS, Spain Hongmei Zeng, Professor, National Central Cancer Registry, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China Liver cancer is the sixth most common cancer and the third leading cause of cancer-related mortality globally. The number of new liver cancer cases will nearly double, from 0.87 million in 2022 to 1.52 million in 2050, if there is no change in the current trend. This webinar aims to foster a global dialogue among healthcare professionals, researchers, and policymakers, and to explore innovative approaches to reduce the burden of liver cancer worldwide. Can't attend the live webinar? By registering you will receive an email with a link to the on-demand version so that you can watch it at your convenience. We hope you can join us for this Lancet Webinar!